首页> Journal of clinical oncology : official journal of the American Society of Clinical Oncology> Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.

Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.

导出原文传递

翻译打印收藏纠错

第一作者： Akhil,Santhosh

第一单位： Department of Medical Oncology, BRAIRCH, AIIMS, Delhi, India.

作者： Akhil,Santhosh ^[1] ; Atul,Sharma ^[1] ; Sameer,Bakhshi ^[1] ; Akash,Kumar ^[2] ; Vinod,Sharma ^[2] ; Prabhat Singh,Malik ^[1] ; Raja,Pramanik ^[1] ; Ajay,Gogia ^[1] ; Chandra Prakash,Prasad ^[3] ; Tushar,Sehgal ^[4] ; Sneha,Gund ^[1] ; Arundhathi,Dev ^[3] ; Winson Y,Cheung ^[5] ; R M,Pandey ^[6] ; Saran,Kumar ^[7] ; Ishaan,Gupta ^[8] ; Atul,Batra ^[1] ; D-TORCH Trial Investigators

作者单位： Department of Medical Oncology, BRAIRCH, AIIMS, Delhi, India. ^[1] Department of Medical Oncology, National Cancer Institute Jhajjar, AIIMS, New Delhi, India. ^[2] Department of Medical Oncology (LAB), BRAIRCH, AIIMS, Delhi, India. ^[3] Department of Laboratory Medicine, AIIMS, Delhi, India. ^[4] Department of Medical Oncology, Tom Baker Cancer Centre Calgary, Calgary, Canada. ^[5] Department of Biostatistics, AIIMS, Delhi, India. ^[6] Kusuma School of Biological Sciences, Indian Institute of Technology, Delhi, India. ^[7] Department of Biomedical Engineering and Biotechnology, Indian Institute of Technology, Delhi, India. ^[8]